Related Experiment Video
Updated: Jul 5, 2025
06:33
Production of Human CRISPR-Engineered CAR-T Cells
Published on: March 15, 2021
13.0K
High-throughput CRISPR technology: a novel horizon for solid organ transplantation
Xiaohan Li1,2, Zhang Chen1,2, Weicong Ye1,2
1Department of Cardiovascular Surgery, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
Frontiers in Immunology
|January 19, 2024
Summary
CRISPR screening identifies effective targets for CRISPR/Cas9 transcriptome editing, addressing organ transplant limitations. This approach enhances graft survival and availability for patients with end-stage organ failure.
Area of Science:
- Genetics and Genomics
- Transplantation Immunology
- Bioengineering
Background:
- Organ transplantation is crucial for end-stage organ failure but faces graft shortage and dysfunction challenges.
- CRISPR/Cas9 technology offers potential solutions for improving graft viability and availability.
Purpose of the Study:
- To review advancements in CRISPR screening for identifying therapeutic targets in gene editing.
- To discuss the application of CRISPR/Cas9 gene editing and CRISPR screening in organ transplantation.
Main Methods:
- Summarizes current CRISPR screening techniques and workflows in various cell types.
- Reviews the integration of CRISPR/Cas9 gene editing with ex vivo organ perfusion systems.
- Analyzes high-throughput CRISPR screening methodologies for target identification.
Main Results:
- CRISPR screening accelerates the identification of effective intervention targets for gene editing.
- CRISPR/Cas9-based transcriptome editing combined with ex vivo perfusion shows promise for pre-implantation graft modification.
Conclusions:
- CRISPR screening is a powerful tool for advancing gene editing strategies in transplantation.
- Prospective applications of CRISPR screening in solid organ transplantation could overcome current therapeutic barriers.
